The DOI matches its Crossref record; 45 of the 45 references it cites were found in a registry or an index.
Cancer Care Ontario and American Society of Clinical Oncology Adjuvant Chemotherapy and Adjuvant Radiation Therapy for Stages I-IIIA Resectable Non–Small-Cell Lung Cancer Guideline
Abstract
Purpose: To determine the role of adjuvant chemotherapy and radiation therapy in patients with completely resected stage IA-IIIA non–small-cell lung cancer (NSCLC). Methods: The Cancer Care Ontario Program in Evidence-Based Care and the American Society of Clinical Oncology convened a Joint Expert Panel in August 2006 to review the evidence and draft recommendations for these therapies. Results: Available data support the use of adjuvant cisplatin-based chemotherapy in completely resected NSCLC; however, the strength of the data and consequent recommendations vary by disease stage. Adjuvant radiation therapy appears detrimental to survival in stages IB and II, with a possible modest benefit in stage IIIA. Conclusion: Adjuvant cisplatin-based chemotherapy is recommended for routine use in patients with stages IIA, IIB, and IIIA disease. Although there has been a statistically significant overall survival benefit seen in several randomized clinical trials (RCTs) enrolling a range of people with completely resected NSCLC, results of subset analyses for patient populations with stage IB disease were not significant, and adjuvant chemotherapy in stage IB disease is not currently recommended for routine use. To date, very few patients with stage IA NSCLC have been enrolled onto RCTs of adjuvant therapy; adjuvant chemotherapy is not recommended in these cases. Evidence from RCTs demonstrates a survival detriment for adjuvant radiotherapy with limited evidence for a reduction in local recurrence. Adjuvant radiation therapy appears detrimental to survival in stage IB and II, and may possibly confer a modest benefit in stage IIIA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Murray, T., Xu, J., & Thun, M. J. (2007) · CA: A Cancer Journal for Clinicians · doi:10.3322/canjclin.57.1.43 · Cited by 7,439
Revisions in the International System for Staging Lung Cancer
Mountain, C. F. (1997) · Chest · doi:10.1378/chest.111.6.1710 · Cited by 4,565
Non-small Cell Lung Cancer Collaborative Group (1995) · BMJ · doi:10.1136/bmj.311.7010.899 · Cited by 2,850
(2004) · New England Journal of Medicine · doi:10.1056/nejmoa031644 · Cited by 2,335
Power and sample size calculations
Dupont, W. D., & Plummer, W. D. (1990) · Controlled Clinical Trials · doi:10.1016/0197-2456(90)90005-m · Cited by 2,092
Vinorelbine plus Cisplatin vs. Observation in Resected Non–Small-Cell Lung Cancer
Winton, T., Livingston, R., Johnson, D., Rigas, J., Johnston, M., Butts, C., Cormier, Y., Goss, G., Inculet, R., Vallieres, E., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043623 · Cited by 1,810
Self-citationDNA Repair by ERCC1 in Non–Small-Cell Lung Cancer and Cisplatin-Based Adjuvant Chemotherapy
Olaussen, K. A., Dunant, A., Fouret, P., Brambilla, E., André, F., Haddad, V., Taranchon, E., Filipits, M., Pirker, R., Popper, H. H., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060570 · Cited by 1,727
Douillard, J.-Y., Rosell, R., De Lena, M., Carpagnano, F., Ramlau, R., Gonzáles-Larriba, J. L., Grodzki, T., Pereira, J. R., Le Groumellec, A., Lorusso, V., et al. (2006) · The Lancet Oncology · doi:10.1016/s1470-2045(06)70804-x · Cited by 1,573
Yusuf, S. (1991) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1991.03470010097038 · Cited by 1,014
Ravdin, P. M., Siminoff, L. A., Davis, G. J., Mercer, M. B., Hewlett, J., Gerson, N., & Parker, H. L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.4.980 · Cited by 996
Stigma, shame, and blame experienced by patients with lung cancer: qualitative study
Chapple, A., Ziebland, S., & McPherson, A. (2004) · BMJ · doi:10.1136/bmj.38111.639734.7c · Cited by 789
Calculating the number needed to treat for trials where the outcome is time to an event
Altman, D. G., & Andersen, P. K. (1999) · BMJ · doi:10.1136/bmj.319.7223.1492 · Cited by 710
The periodic health examination. Canadian Task Force on the Periodic Health Examination.
(1979) · PubMed · Cited by 671
Scagliotti, G. V. (2003) · CancerSpectrum Knowledge Environment · doi:10.1093/jnci/djg059 · Cited by 593
Population-Based Validation of the Prognostic Model ADJUVANT! for Early Breast Cancer
Olivotto, I. A., Bajdik, C. D., Ravdin, P. M., Speers, C. H., Coldman, A. J., Norris, B. D., Davis, G. J., Chia, S. K., & Gelmon, K. A. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.06.178 · Cited by 567
The Challenge of Subgroup Analyses — Reporting without Distorting
Lagakos, S. W. (2006) · New England Journal of Medicine · doi:10.1056/nejmp068070 · Cited by 504
Lally, B. E., Zelterman, D., Colasanto, J. M., Haffty, B. G., Detterbeck, F. C., & Wilson, L. D. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2005.04.6110 · Cited by 469
Keller, S. M., Adak, S., Wagner, H., Herskovic, A., Komaki, R., Brooks, B. J., Perry, M. C., Livingston, R. B., & Johnson, D. H. (2000) · New England Journal of Medicine · doi:10.1056/nejm200010263431703 · Cited by 446
Breaking Bad News About Cancer: Patients’ Preferences for Communication
Parker, P. A., Baile, W. F., de Moor, C., Lenzi, R., Kudelka, A. P., & Cohen, L. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.7.2049 · Cited by 388
WALLER, D., PEAKE, M., STEPHENS, R., GOWER, N., MILROY, R., PARMAR, M., RUDD, R., SPIRO, S., & ONBEHALFOFALLBLTPARTICIPANTS (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.03.041 · Cited by 387
What Happens to Patients Undergoing Lung Cancer Surgery?
Handy, J. R., Asaph, J. W., Skokan, L., Reed, C. E., Koh, S., Brooks, G., Douville, E. C., Tsen, A. C., Ott, G. Y., & Silvestri, G. A. (2002) · Chest · doi:10.1378/chest.122.1.21 · Cited by 308
BRCA1 mRNA expression levels as an indicator of chemoresistance in lung cancer
Taron, M., Rosell, R., Felip, E., Mendez, P., Souglakos, J., Ronco, M. S., Queralt, C., Majo, J., Sanchez, J. M., Sanchez, J. J., et al. (2004) · Human Molecular Genetics · doi:10.1093/hmg/ddh260 · Cited by 307
Hamada, C., Tanaka, F., Ohta, M., Fujimura, S., Kodama, K., Imaizumi, M., & Wada, H. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.09.017 · Cited by 284
K-ras Mutations in Non-Small-Cell Lung Carcinoma: A Review
Aviel-Ronen, S., Blackhall, F. H., Shepherd, F. A., & Tsao, M.-S. (2006) · Clinical Lung Cancer · doi:10.3816/clc.2006.n.030 · Cited by 224
Self-citationDoctor-patient communication about breast cancer adjuvant therapy.
Siminoff, L. A., Fetting, J. H., & Abeloff, M. D. (1989) · Journal of Clinical Oncology · doi:10.1200/jco.1989.7.9.1192 · Cited by 217
Berghmans, T., Paesmans, M., Meert, A. P., Mascaux, C., Lothaire, P., Lafitte, J. J., & Sculier, J. P. (2005) · Lung Cancer · doi:10.1016/j.lungcan.2005.01.002 · Cited by 212
Hotta, K., Matsuo, K., Ueoka, H., Kiura, K., Tabata, M., & Tanimoto, M. (2004) · Journal of Clinical Oncology · doi:10.1200/jco.2004.01.153 · Cited by 197
Strauss, G. M., Herndon, J. E., Maddaus, M. A., Johnstone, D. W., Johnson, E. A., Watson, D. M., Sugarbaker, D. J., Schilsky, R. A., Vokes, E. E., & Green, M. R. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.7007 · Cited by 178
Feld, R., Rubinstein, L., Thomas, P. A., & The Lung Cancer Study Group (1993) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/85.4.299 · Cited by 171
Patients’ Perceptions of Receiving Bad News About Cancer
Ptacek, J. T., & Ptacek, J. J. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.21.4160 · Cited by 168
Do doctors know when their patients don't?
Quirt, C. F., Mackillop, W. J., Ginsburg, A. D., Sheldon, L., Brundage, M., Dixon, P., & Ginsburg, L. (1997) · Lung Cancer · doi:10.1016/s0169-5002(97)00048-2 · Cited by 163
Pignon, J., Tribodet, H., Scagliotti, G. V., Douillard, J., Shepherd, F. A., Stephens, R. J., & Chevalier, T. L. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.7008 · Cited by 157
Self-citationUchitomi, Y., Mikami, I., Nagai, K., Nishiwaki, Y., Akechi, T., & Okamura, H. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2003.12.139 · Cited by 150
Compliance with post-operative adjuvant chemotherapy in non-small cell lung cancer
Alam, N. Z., Shepherd, F. A., Winton, T. L., Graham, B., Johnson, D. H., Livingston, R. B., Rigas, J. R., Whitehead, M., Ding, K., & Seymour, L. (2004) · Lung Cancer · doi:10.1016/j.lungcan.2004.08.016 · Cited by 134
Self-citationPostoperative chemotherapy for non–small cell lung cancer: A systematic review and meta-analysis
Sedrakyan, A., van der Meulen, J., O'Byrne, K. J., Prendiville, J., Hill, J., & Treasure, T. (2004) · Journal of Thoracic and Cardiovascular Surgery · doi:10.1016/j.jtcvs.2004.04.027 · Cited by 119
Discussing Adjuvant Cancer Therapy
Leighl, N. B., Gattellari, M., Butow, P. N., Brown, R., & Tattersall, M. H. N. (2001) · Journal of Clinical Oncology · doi:10.1200/jco.2001.19.6.1768 · Cited by 89
Chao, C., Studts, J. L., Abell, T. D., Hadley, T. J., Roetzer, L. M., Dineen, S. P., Lorenz, D., YoussefAgha, A. H., & McMasters, K. M. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.06.025 · Cited by 88
Dautzenberg, B., Chastang, C., Arriagada, R., Chevalier, T. L., Belpomme, D., Hurdebourcq, M., Lebeau, B., Fabre, C., Charvolin, P., & Guerin, R. A. (1995) · Cancer · Cited by 87
Setting Goals to Maintain Hope
Roenn, J. H. V., & von Gunten, C. F. (2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.10.161 · Cited by 63
(2003) · Journal of Clinical Oncology · doi:10.1200/jco.2003.04.154 · Cited by 46
Stewart, L. A., Burdett, S., Tierney, J. F., & Pignon, J. (2007) · Journal of Clinical Oncology · doi:10.1200/jco.2007.25.18_suppl.7552 · Cited by 40
The Rationale for Adjuvant Chemotherapy in Stage I Non-small Cell Lung Cancer
Horn, L., Sandler, A. B., Putnam, J. B., & Johnson, D. H. (2007) · Journal of Thoracic Oncology · doi:10.1097/01.jto.0000268669.64625.bb · Cited by 20
Management of early-stage lung cancer: past, present, and future adjuvant trials.
Strauss, G. M. (2006) · PubMed · Cited by 8
Cited by
Non-small cell lung cancer: current treatment and future advances
Zappa, C., & Mousa, S. A. (2016) · Translational Lung Cancer Research · doi:10.21037/tlcr.2016.06.07 · Cited by 1,944
Treatment of Stage I and II Non-small Cell Lung Cancer
Howington, J. A., Blum, M. G., Chang, A. C., Balekian, A. A., & Murthy, S. C. (2013) · Chest · doi:10.1378/chest.12-2359 · Cited by 1,440
Strauss, G. M., Herndon, J. E., Maddaus, M. A., Johnstone, D. W., Johnson, E. A., Harpole, D. H., Gillenwater, H. H., Watson, D. M., Sugarbaker, D. J., Schilsky, R. L., et al. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2008.16.4855 · Cited by 974
Azzoli, C. G., Baker, S., Temin, S., Pao, W., Aliff, T., Brahmer, J., Johnson, D. H., Laskin, J. L., Masters, G., Milton, D., et al. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.23.5622 · Cited by 915
Self-citation_, _. (2008) · Journal of the National Comprehensive Cancer Network · doi:10.6004/jnccn.2008.0021 · Cited by 735
Metadata
- Authors
- Pisters, K. M. W., Evans, W. K., Azzoli, C. G., Kris, M. G., Smith, C. A., Desch, C. E., Somerfield, M. R., Brouwers, M. C., Darling, G., Ellis, P. M., Gaspar, L. E., Pass, H. I., Spigel, D. R., Strawn, J. R., Ung, Y. C., & Shepherd, F. A.
- Venue
- Journal of Clinical Oncology
- Published
- 2007-12-01
- Volume
- 25
- Issue
- 34
- Pages
- 5506-5518
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2168150041
- Cited by
- 363
- References
- 45
- FWCI
- 21.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.